Incyte’s Minjuvi (Tafasitamab) Combination Gains the EC Approval for R/R Follicular Lymphoma (FL)
Shots: Ref: Incyte | Image: Incyte | Press Release Related News: Incyte Reports Positive P-I Data of INCA033989 in…
Read article →
Kyverna Therapeutics Reports Topline P-II (KYSA-8) Trial Data of Miv-cel in Stiff Person Syndrome (SPS)
Shots: Ref: Kyverna| Image: Kyverna | Press Release Related News: InnoCare Pharma Reports P-IIb Study Findings of…
Read article →
May Health’s Anavi System Receives the European CE Mark for Women with PCOS-Related Infertility
Shots: Ref: Business Wire | Image: May Health | Press Release Related News: Zenflow Receives the US FDA Approval for…
Read article →
Vir Biotechnology Licenses Tobevibart & Elebsiran Combination to Norgine in EU, Australia and New Zealand
Shots: Ref: PR Newswire | Image: Vir & Norgine | Press Release Related News: Vir Biotechnology Reports First Patient…
Read article →
Formycon Partners with MS Pharma to Commercialize FYB206 (Biosimilar, Keytruda) in the MENA Region
Shots: Ref: PRnewswire | Image: Formycon & MS Pharma | Press Release Related News: Actor Pharmaceuticals and Megalabs…
Read article →
Capricor Therapeutics Reports the Topline P-III (HOPE-3) Trial Data on Deramiocel for Duchenne Muscular Dystrophy
Shots: Ref: Capricor | Image: Capricor | Press Release Related News: Santhera Pharmaceuticals Reports Health Canada’s…
Read article →
Iolyx Therapeutics Enters a Strategic Deal with Laboratoires Théa for ILYX-002 to Treat Ocular Surface Conditions
Shots: Ref: GlobeNewswire | Image: Iolyx & Théa | Press Release Related News: RemeGen Enters a Licensing Agreement…
Read article →
Eli Lilly’s Jaypirca Receives the FDA Approval for R/R Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL)
Shots: Ref: Eli Lilly | Image: Eli Lilly | Press Release Related News: SanegeneBio Collaborates with Eli Lilly to…
Read article →